InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
10
T+90 hit rate
0%
T+90 mean return
-36.4%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Trigilio Jeffrey, Chief Financial Officer. Director active across 2 companies, notably Cullinan Oncology, Inc.. In total, 23 filings have been logged. Split: 0 buy · 10 sells. Total volume traded: €58k. Activity tracked since 8 September 2021. The latest transaction was filed on 20 April 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations23 total
11,538 shares0Common StockSEC:0001214659-26-004971:0
4,000 shares0Common StockSEC:0001214659-26-004709:0
1,632 shares@ US$36.76100.0% of flowCommon StockSEC:0001214659-26-004709:1
50,000 shares0Common StockSEC:0000950170-24-019458:0
1,920 shares@ US$8.505.7% of flowCommon StockSEC:0000950170-23-072754:0
398 shares@ US$8.221.1% of flowCommon StockSEC:0000950170-23-071985:0
1,926 shares@ US$7.815.3% of flowCommon StockSEC:0000950170-23-070143:0
2,340 shares@ US$9.087.4% of flowCommon StockSEC:0000950170-23-031858:0
399 shares@ US$12.941.8% of flowCommon StockSEC:0000950170-23-029158:0
319 shares@ US$13.111.5% of flowCommon StockSEC:0000950170-23-027985:0
399 shares@ US$8.761.2% of flowCommon StockSEC:0000899243-23-013358:0
347 shares@ US$8.781.1% of flowCommon StockSEC:0000950170-23-022548:0
398 shares@ US$10.711.5% of flowCommon StockSEC:0000950170-23-013702:0
318 shares@ US$10.221.1% of flowCommon StockSEC:0000899243-23-011298:0
399 shares@ US$11.321.6% of flowCommon StockSEC:0000899243-23-009718:0
47,000 shares0Common StockSEC:0000899243-23-005736:0
201 shares@ US$8.970.6% of flowCommon StockSEC:0000899243-23-001157:0
1,451 shares@ US$10.905.8% of flowCommon StockSEC:0000899243-22-025080:0
37,500 shares0Common StockSEC:0000899243-22-006412:0
8,000 shares@ US$4.300.0031% mcap17.6% of flowCommon StockSEC:0000899243-21-040454:0
8,000 shares@ US$4.3011.3% of flowCommon StockSEC:0000899243-21-040454
15,000 shares@ US$4.300.0056% mcap32.4% of flowCommon StockSEC:0000899243-21-035417:0
15,000 shares@ US$4.3020.8% of flowCommon StockSEC:0000899243-21-035417
23 of 23 declarations
About Trigilio Jeffrey
Jeffrey Trigilio is the Chief Financial Officer at Cullinan Oncology, Inc. He is responsible for the financial management of the company, including financial planning, analysis, and risk management. With a strong background in the healthcare sector, he plays a key role in developing financial strategies that support the company's mission to develop innovative cancer treatments.
